Skip to main content
Figure 2 | BMC Cardiovascular Disorders

Figure 2

From: Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus

Figure 2

Multivariable logistic regression analyses showing odds ratios for claiming secondary prevention therapy after first myocardial infarction during 2003–2006 for acetylsalicylic acid (ASA), angiotensin-converting enzyme inhibitors or angiotensin-2 receptor blockers (ACEIs/ARBs), β-blockers, clopidogrel, and statins. DM: diabetes mellitus. Analyses were adjusted for age, gender, comorbidity, and concomitant pharmacotherapy.

Back to article page